Human mu-opioid receptor gene A118G polymorphism predicts the efficacy of tramadol/acetaminophen combination tablets (ultracet) in oxaliplatin-induced painful neuropathy

Cancer

Volumn 118, Issue 6, 2012, Pages 1718-1725

  Liu, Yu Chang ^a   Wang, Wei Shu ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

OPRM1; oxaliplatin; painful neuropathy; polymorphism; Ultracet

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; PARACETAMOL PLUS TRAMADOL;

ADULT; AGED; AMINO ACID SUBSTITUTION; ANALGESIC ACTIVITY; ARTICLE; CHINESE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SENSITIVITY; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUROLOGIC EXAMINATION; NEUROPATHY; OPRM1 GENE; PAIN ASSESSMENT; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; STOMACH CANCER; VISUAL ANALOG SCALE;

ACETAMINOPHEN; ADULT; AGED; ANALGESICS; ANTINEOPLASTIC AGENTS; DRUG COMBINATIONS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; PERIPHERAL NERVOUS SYSTEM DISEASES; POLYMORPHISM, GENETIC; RECEPTORS, OPIOID, MU; TRAMADOL;

EID: 84858001528     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26430     Document Type: Article

References (46)

1. Kaley TJ, Deangelis LM,. Therapy of chemotherapy-induced peripheral neuropathy. Br J Haematol. 2009; 145: 3-14.
2. Wilson RH, Lehky T, Thomas RR, et al. Acute oxaliplatin-induced peripheral nerve hyperexcitability. J Clin Oncol. 2002; 20: 1767-1774. (Pubitemid 34273265)
3. Cohen KL, Harris S,. Efficacy and safety of nonsteroidal anti-inflammatory drugs in the therapy of diabetic neuropathy. Arch Intern Med. 1987; 147: 1442-1444. (Pubitemid 17122120)
4. Hammack JE, Michalak JC, Loprinzi CL, et al. Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy. Pain. 2002; 98: 195-203. (Pubitemid 34722482)
5. Kautio AL, Haanpaa M, Saarto T, Kalso E,. Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms. J Pain Symptom Manage. 2008; 35: 31-39. (Pubitemid 350299098)
6. von Delius S, Eckel F, Wagenpfeil S, et al. Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: final results of a randomised, controlled, multicenter phase II study. Invest New Drugs. 2007; 25: 173-180. (Pubitemid 46020877)
7. Argyriou AA, Chroni E, Polychronopoulos P, et al. Efficacy of oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathy. Neurology. 2006; 67: 2253-2255. (Pubitemid 46035491)
8. Tallarida RJ, Raffa RB,. Testing for synergism over a range of fixed ratio drug combinations: replacing the isobologram. Life Sci. 1996; 58: PL23-PL28. (Pubitemid 126635405)
9. Bennett RM, Kamin M, Karim R, Rosenthal N,. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J Med. 2003; 114: 537-545. (Pubitemid 36577256)
10. Peloso PM, Fortin L, Beaulieu A, Kamin M, Rosenthal N,. Analgesic efficacy and safety of tramadol/ acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial. J Rheumatol. 2004; 31: 2454-2463. (Pubitemid 39603097)
11. Emkey R, Rosenthal N, Wu SC, Jordan D, Kamin M,. Efficacy and safety of tramadol/acetaminophen tablets (Ultracet) as add-on therapy for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal antiinflammatory drug: a multicenter, randomized, double-blind, placebo-controlled trial. J Rheumatol. 2004; 31: 150-156. (Pubitemid 38067537)
12. Ho ML, Chung CY, Wang CC, Lin HY, Hsu NC, Chang CS,. Efficacy and safety of tramadol/acetaminophen in the treatment of breakthrough pain in cancer patients. Saudi Med J. 2010; 31: 1315-1319.
13. Hayashida M, Nagashima M, Satoh Y, et al. Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype. Pharmacogenomics. 2008; 9: 1605-1616.
14. Hernandez-Avila CA, Wand G, Luo X, Gelernter J, Kranzler HR,. Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1). Am J Med Genet B Neuropsychiatr Genet. 2003; 118: 60-65. (Pubitemid 37064077)
15. Klepstad P, Rakvag TT, Kaasa S, et al. The 118A>G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease. Acta Anaesthesiol Scand. 2004; 48: 1232-1239. (Pubitemid 39490855)
16. Chou WY, Wang CH, Liu PH, Liu CC, Tseng CC, Jawan B,. Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia consumption after total abdominal hysterectomy. Anesthesiology. 2006; 105: 334-337. (Pubitemid 44148178)
17. Fukuda K, Hayashida M, Ide S, et al. Association between OPRM1 gene polymorphisms and fentanyl sensitivity in patients undergoing painful cosmetic surgery. Pain. 2009; 147: 194-201.
18. Zadina JE, Hackler L, Ge LJ, Kastin AJ,. A potent and selective endogenous agonist for the mu-opiate receptor. Nature. 1997; 386: 499-502. (Pubitemid 27164076)
19. Bond C, LaForge KS, Tian M, et al. Single nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A. 1998; 95: 9608-9613. (Pubitemid 28506279)
20. Tan EC, Tan CH, Karupathivan U, Yap EP,. Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations. Neuroreport. 2003; 14: 569-572. (Pubitemid 36528992)
21. Sia AT, Lim Y, Lim EC, et al. A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia. Anesthesiology. 2008; 109: 520-526.
22. Wolfe GI, Trivedi JR,. Painful peripheral neuropathy and its nonsurgical treatment. Muscle Nerve. 2004; 30: 3-19. (Pubitemid 38880320)
23. Watson CP, Moulin D, Watt-Watson J, Gordon A, Eisenhoffer J,. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain. 2003; 105: 71-78. (Pubitemid 37162475)
24. Sindrup SH, Andersen G, Madsen C, Smith T, Brosen K, Jensen TS,. Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial. Pain. 1999; 83: 85-90. (Pubitemid 29446160)
25. Binder A, Stengel M, Maag R, et al. Pain in oxaliplatin-induced neuropathy-sensitization in the peripheral and central nociceptive system. Eur J Cancer. 2007; 43: 2658-2663. (Pubitemid 350151837)
26. Gamelin L, Boisdron-Celle M, Delva R, et al. Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-fluorouracil and leucovorin for advanced colorectal cancer. Clin Cancer Res. 2004; 10: 4055-4061. (Pubitemid 38812481)
27. Joseph EK, Levine JD,. Comparison of oxaliplatin- and cisplatin-induced painful peripheral neuropathy in the rat. J Pain. 2009; 10: 534-541.
28. Cascinu S, Catalano V, Cordella L, et al. Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double blind, placebo-controlled trial. J Clin Oncol. 2002; 20: 3478-3483.
29. Chen YC, Tzeng CH, Chen PM, et al. Influence of GSTP1 I105V polymorphism on cumulative neuropathy and outcome to FOLFOX-4 treatment in Asian patients with colorectal carcinoma. Cancer Sci. 2010; 101: 530-535.
30. Onofrio BM, Yaksh TL,. Long-term pain relief produced by intrathecal morphine infusion in 53 patients. J Neurosurg. 1990; 72: 200-209. (Pubitemid 20087708)
31. Shigeta Y, Kasai S, Han W, et al. Association of morphine-induced antinociception with variations in the 5′ flanking and 3′ untranslated regions of the mu opioid receptor gene in 10 inbred mouse strains. Pharmacogenet Genomics. 2008; 18: 927-936.
32. Befort K, Filliol D, Decaillot FM, Gaveriaux-Ruff C, Hoehe MR, Kieffer BL,. A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling. J Biol Chem. 2001; 276: 3130-3137.
33. Fillingim RB, Kaplan L, Staud R, et al. The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. J Pain. 2005; 6: 159-167. (Pubitemid 40365019)
34. Wand GS, McCaul M, Yang X, et al. The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology. 2002; 26: 106-114. (Pubitemid 34075281)
35. Chang A, Parikh P, Thongprasert S, et al. Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: subset analysis from the ISEL study. J Thorac Oncol. 2006; 1: 847-855. (Pubitemid 47181391)
36. Liu CY, Chen PM, Chiou TJ, et al. UGT1A1 28 polymorphism predicts irinotecan-induced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinoma. Cancer. 2008; 112: 1932-1940.
37. Paar WD, Frankus P, Dengler HJ,. The metabolism of tramadol by human liver microsomes. Clin Investig. 1992; 70: 708-710.
38. Scott LJ, Perry CM,. Tramadol: a review of its use in perioperative pain. Drugs. 2000; 60: 139-176. (Pubitemid 30598822)
39. Stamer UM, Musshoff F, Kobilay M, Madea B, Hoeft A, Stuber F,. Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes. Clin Pharmacol Ther. 2007; 82: 41-47. (Pubitemid 46944194)
40. Hays L, Reid C, Doran M, Geary K,. Use of methadone for the treatment of diabetic neuropathy. Diabetes Care. 2005; 28: 485-487. (Pubitemid 40170968)
41. Bruera E, Sweeney C,. Methadone use in cancer patients with pain: a review. J Palliat Med. 2002; 5: 127-138. (Pubitemid 34111584)
42. Davis M, Walsh D,. Methadone for relief of cancer pain: a review of pharmokinetics, pharmacodynamics, drug interactions and protocols of administration. Support Care Cancer. 2001; 9: 73-83. (Pubitemid 32246453)
43. Pascual D, Goicoechea C, Burgos E, Martin MI,. Antinociceptive effect of 3 common analgesic drugs on peripheral neuropathy induced by paclitaxel in rats. Pharmacol Biochem Behav. 2010; 95: 331-337.
44. Moulin DE, Palma D, Watling C, Schulz V,. Methadone in the management of intractable neuropathic noncancer pain. Can J Neurol Sci. 2005; 32: 340-343. (Pubitemid 41232808)
45. Mercadante S, Casuccio A, Fulfaro F, et al. Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. J Clin Oncol. 2001; 19: 2898-2904. (Pubitemid 32538200)
46. Parsons HA, de la Cruz M, El Osta B, et al. Methadone initiation and rotation in the outpatient setting for patients with cancer pain. Cancer. 2010; 116: 520-528.